News

Dr. Eyal Morag has joined the Advisory Board of OnConquer Medical. An interventional radiologist, he brings expertise in endovascular procedures, intravascular device deployment, clinical workflow integration, and translational feasibility, advising on advancing innovative cancer therapies from concept to clinical practice.

Prof. Gil Bar-Sela has joined the Advisory Board of OnConquer Medical. A renowned cancer specialist with over 20 years of experience, he focuses on supportive care for patients and has participated in international clinical trials studying treatment-related side effects, advising on strategies to improve patient outcomes in cancer therapy.

OnConquer Medical secures pre-seed funding with support from the Israel Innovation Authority to advance early-stage development.

Dr. Chaya Brodie has joined the Scientific Board of OnConquer Medical. An Emeritus professor at Bar-Ilan University and a leading cancer biologist, she brings extensive expertise in tumor progression and metastasis. She will advise on perioperative biology and translational study design.

Yuval Shaked joins the Scientific Board of OnConquer Medical, bringing expertise in metastasis, tumor microenvironment, and translational oncology from the Technion – Israel Institute of Technology.